Evidence map›Paper›PMID 25249279›Full record

ArticlemBio2014

Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness.

Alexander Zaborin, Daniel Smith, Kevin Garfield, John Quensen, Baddr Shakhsheer, Matthew Kade, Matthew Tirrell, James Tiedje, Jack A Gilbert, Olga Zaborina and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03720093 (Exploratory Analysis of Pulmonary Microbiome in Patients Intubated for Non-pulmonary Conditions- A Pilot Study), which is not on this map. Cited by 214 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 4 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03720093 completednot on this mapstarted 2017, after this paper: background citation

Exploratory Analysis of Pulmonary Microbiome in Patients Intubated for Non-pulmonary Conditions- A Pilot Study

TypeobservationalSponsorUniversity of Milano BicoccaRan2017 to 2020Enrolled65ConditionsIntubation Complication
3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 4 syntheses or guidelines pooled it, 356 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. InvestigatingIJID regions · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Indole-3-acetic acid derived fromFrontiers in immunology · 2026
    Article
  20. Review

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alexander ZaborinUniversity of Chicago, Chicago, Illinois, USA.
Daniel SmithArgonne National Laboratory, Argonne, Illinois, USA.
Kevin GarfieldMichigan State University, East Lansing, Michigan, USA.
John QuensenMichigan State University, East Lansing, Michigan, USA.
Baddr ShakhsheerUniversity of Chicago, Chicago, Illinois, USA.
Matthew KadeUniversity of Chicago, Chicago, Illinois, USA.
Matthew TirrellUniversity of Chicago, Chicago, Illinois, USA.
James TiedjeMichigan State University, East Lansing, Michigan, USA.
Jack A Gilbert
Olga ZaborinaUniversity of Chicago, Chicago, Illinois, USA jalverdy@surgery.bsd.uchicago.edu ozaborin@surgery.bsd.uchicago.edu.
John C AlverdyUniversity of Chicago, Chicago, Illinois, USA jalverdy@surgery.bsd.uchicago.edu ozaborin@surgery.bsd.uchicago.edu.
University of Chicago · USMichigan State University · USArgonne National Laboratory · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERYR01GM062344 · NIGMS · UNIVERSITY OF CHICAGO · PI ALVERDY, JOHN C · 2001 to 2025
$9.2M
NCATS NIH HHS UL1 TR000430NIGMS NIH HHS R01 2R01GM062344-13A1NIGMS NIH HHS R01 GM062344
6 · The paper itself

Abstract

unlabelledWe analyzed the 16S rRNA amplicon composition in fecal samples of selected patients during their prolonged stay in an intensive care unit (ICU) and observed the emergence of ultra-low-diversity communities (1 to 4 bacterial taxa) in 30% of the patients. Bacteria associated with the genera Enterococcus and Staphylococcus and the family Enterobacteriaceae comprised the majority of these communities. The composition of cultured species from stool samples correlated to the 16S rRNA analysis and additionally revealed the emergence of Candida albicans and Candida glabrata in ~75% of cases. Four of 14 ICU patients harbored 2-member pathogen communities consisting of one Candida taxon and one bacterial taxon. Bacterial members displayed a high degree of resistance to multiple antibiotics. The virulence potential of the 2-member communities was examined in C. elegans during nutrient deprivation and exposure to opioids in order to mimic local conditions in the gut during critical illness. Under conditions of nutrient deprivation, the bacterial members attenuated the virulence of fungal members, leading to a "commensal lifestyle." However, exposure to opioids led to a breakdown in this commensalism in 2 of the ultra-low-diversity communities. Application of a novel antivirulence agent (phosphate-polyethylene glycol [Pi-PEG]) that creates local phosphate abundance prevented opioid-induced virulence among these pathogen communities, thus rescuing the commensal lifestyle. To conclude, the gut microflora in critically ill patients can consist of ultra-low-diversity communities of multidrug-resistant pathogenic microbes. Local environmental conditions in gut may direct pathogen communities to adapt to either a commensal style or a pathogenic style. IMPORTANCE: During critical illness, the normal gut microbiota becomes disrupted in response to host physiologic stress and antibiotic treatment. Here we demonstrate that the community structure of the gut microbiota during prolonged critical illness is dramatically changed such that in many cases only two-member pathogen communities remain. Most of these ultra-low-membership communities display low virulence when grouped together (i.e., a commensal lifestyle); individually, however, they can express highly harmful behaviors (i.e., a pathogenic lifestyle). The commensal lifestyle of the whole community can be shifted to a pathogenic one in response to host factors such as opioids that are released during physiologic stress and critical illness. This shift can be prevented by using compounds such as Pi-PEG15-20 that interrupt bacterial virulence expression. Taking the data together, this report characterizes the plasticity seen with respect to the choice between a commensal lifestyle and a pathogenic lifestyle among ultra-low-diversity pathogen communities that predominate in the gut during critical illness and offers novel strategies for prevention of sepsis.

Indexed as

Critical IllnessMicrobiotaAnimalsAnti-Bacterial AgentsCaenorhabditis elegansCandida albicansDrug Resistance, BacterialDrug Resistance, FungalEnterobacteriaceaeEnterococcusFecesGastrointestinal TractGene Expression ProfilingHumansIntensive Care UnitsRNA, Ribosomal, 16SAnti-Bacterial AgentsRNA, Ribosomal, 16SVirulence Factors

Identifiers

PMID25249279
PMCPMC4173762
OpenAlexW2112208246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.